Molecular profiling of chordoma

International Journal of Oncology

Volumn 44, Issue 4, 2014, Pages 1041-1055

  Scheil Bertram, Stefanie ^a,b   Kappler, Roland ^c   Von Baer, Alexandra ^a   Hartwig, Erich ^d   Sarkar, Michael ^e   Serra, Massimo ^f   Brüderlein, Silke ^a   Westhoff, Bettina ^g   Melzner, Ingo ^a   Bassaly, Birgit ^h   Herms, Jochen ⁱ   Hugo, Heinz Hermann ^j   Schulte, Michael ^d   Möller, Peter ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Ev Diakonissenanstalt ^*  (Germany)

^e Karl Olga Krankenhaus   (Germany)

^f RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h JUSTUS LIEBIG UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j UNIVERSITY OF KIEL   (Germany)

more..

Author keywords

Chondrosarcoma; Chordoma; Comparative genomic hybridization; Fluorescence in situ hybridization; GeneChip

Indexed keywords

BRACHYURY PROTEIN; FETOPROTEIN; T BOX TRANSCRIPTION FACTOR; TUMOR MARKER;

AGED; BIOSYNTHESIS; BONE TUMOR; CHONDROSARCOMA; CHORDOMA; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR RECURRENCE;

AGED; BONE NEOPLASMS; CELL LINE, TUMOR; CHONDROSARCOMA; CHORDOMA; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; FETAL PROTEINS; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-BOX DOMAIN PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894422586     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2268     Document Type: Article

References (34)

1. Dorfman HD and Czerniak B (eds): Bone tumors. Mosby, St. Louis, MO, 1998.
2. Mirra JM, Nelson SD, Della Rocca C and Mertens F: Chordoma. In: Pathology and Genetics of Tumors of Soft Tissue and Bone. World Health Organization Classification of Tumors. Fletcher CDM, Unni KK and Mertens F (eds). IARC Press, Lyon, pp316-317, 2002.
3. Dewaele B, Maggiani F, Floris G, Ampe M, Vanspauwen V, Wozniak A, Debiec-Rychter M and Sciot R: Frequent activation of EGFR in advanced chordomas. Clin Sarcoma Res 25: 4, 2011.
4. Diaz RJ, Guduk M, Romagnuolo R, Smith CA, Northcott P, Shih D, Berisha F, Flanagan A, Munoz DG, Cusimano MD, Pamir MN and Rutka JT: High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis. Neoplasia 14: 788-798, 2012.
5. Shalaby AA, Presneau N, Idowu BD, Thompson L, Briggs TR, Tirabosco R, Diss TC and Flanagan AM: Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas. Mod Pathol 22: 996-1005, 2009.
6. Stacchiotti S, Tamborini E, Lo Vullo S, Bozzi F, Messina A, Morosi C, Casale A, Crippa F, Conca E, Negri T, Palassini E, Marrari A, Palmerini E, Mariani L, Gronchi A, Pilotti S and Casali PG: Phase II study on lapatinib in advanced EGFR-positive chordoma. Ann Oncol 24: 1931-1936, 2013.
7. Scheil S, Bruederlein S, Liehr T, Starke H, Herms J, Schulte M and Moeller P: Genome wide analysis of 16 chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32: 203-211, 2001.
8. Larizza L, Mortini P and Riva P: Update on the cytogenetics and molecular genetics of chordoma. Hered Cancer Clin Pract 3: 29-41, 2005.
9. Kelley MJ, Korczak JF, Sheridan E, Yang X, Goldstein AM and Parry DM: Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33. Am J Hum Genet 69: 454-460, 2001.
10. Szuhai K and Hogendoorn PC: 'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma. J Pathol 228: 261-265, 2012.
11. Presneau N, Shalaby A, Ye H, Pillay N, Halai D, Idowu B, Tirabosco R, Whitwell D, Jacques TS, Kindblom LG, Brüderlein S, Möller P, Leithner A, Liegl B, Amary FM, Athanasou NN, Hogendoorn PC, Mertens F, Szuhai K and Flanagan AM: Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 223: 327-335, 2011.
12. Bruederlein S, Sommer JB, Meltzer PS, Li S, Osada T, Ng D, Möller P, Alcorta DA and Kelley MJ: Molecular characterization of putative chordoma cell lines. Sarcoma 2010: 630129, 2010.
13. Fisher LW Hawkins GR, Tuross N and Termine JD: Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem 262: 9702-9708, 1987.
14. Straeter J, Walczak H, Pukrop T, von Müller L, Hasel C, Kornmann M, Mertens T and Möller P: TRAIL and is receptors in the colonic epithelium: a putative role in the defense of viral infections. Gastroenterology 122: 659-666, 2002.
15. Gisselsson D, Pålsson E, Höglund M, Domanski H, Mertens F, Pandis N, Sciot R, Dal Cin P, Bridge JA and Mandahl N: Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes Chromosomes Cancer 33: 133-140, 2002.
16. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD and Eberwine JH: Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 87: 1663-1667, 1990.
17. Kappler R, Hess I, Schlegel J and Hahn H: Transcriptional up-regulation of Gadd45a in Patched-associated medulloblastoma. Int J Oncol 25: 113-120, 2004.
18. Ruiz I, Altaba A, Sánchez P and Dahmane N: Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2: 361-372, 2002.
19. Kappler R, Calzada-Wack J, Schnitzbauer U, Koleva M, Herwig A, Piontek G, Graedler F, Adamski J, Heinzmann U, Schlegel J, Hemmerlein B, Quintanilla-Martinez L and Hahn H: Molecular characterization of Patched-associated rhabdomyosarcoma. J Pathol 200: 348-356, 2003.
20. Hallor KH, Staaf J, Jönsson G, Heidenblad M, Vult von Steyern F, Bauer HC, Ijszenga M, Hogendoorn PC, Mandahl N, Szuhai K and Mertens F: Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer 98: 434-442, 2008.
21. Le LP, Nielsen GP, Rosenberg AE, Thomas D, Batten JM, Deshpande V, Schwab J, Duan Z, Xavier RJ, Hornicek FJ and Iafrate AJ: Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One 6: e18846, 2011.
22. Rittling SR and Chambers AF: Role of ostopontin in tumour progression. Br J Cancer 17: 1877-1881, 2004.
23. Otto WR and Rao J: Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage. Cell Prolif 37: 97-110, 2004.
24. Edwards YH, Putt W, Lekoape KM, Stott D, Fox M, Hopkinson DA and Sowden J: The human homolog T of the mouse T (Brachyury) gene; gene structure, cDNA sequence, and assignment to chromosome 6q27. Genome Res 6: 226-233, 1996.
25. Hsu W, Mohyeldin A, Shah SR, Ap Rhys CM, Johnson LF, Sedora-Roman NI, Kosztowski TA, Awad OA, McCarthy EF, Loeb DM, Wolinsky JP, Gokaslan ZL and Quiñones-Hinojosa A: Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target. J Neurosurg 115: 760-769, 2011.
26. Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM and Kelley MJ: T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet 41: 1176-1178, 2009.
27. Nelson AC, Pillay N, Henderson S, Presneau N, Tirabosco R, Halai D, Berisha F, Flicek P, Stemple DL, Stern CD, Wardle FC and Flanagan AM: An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma. J Pathol 228: 274-285, 2012.
28. Launay SG, Chetaille B, Medina F, Perrot D, Nazarian S, Guiramand J, Moureau-Zabotto L and Bertucci F: Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review. BMC Cancer 11: 423, 2011.
29. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schluns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H and Dietel M: CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 9: 4909-4913, 2004.
30. Kristiansen G, Pilarsky C, Pervan J, Sturzebecher B, Stephan C, Jung K, Loening S, Rosenthal A and Dietel M: CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 58: 183-192, 2004.
31. Sabatier R, Finetti P, Adelaide J, Guille A, Borg JP, Chaffanet M, Lane J, Birnbaum D and Bertucci F: Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS One 6: e27656, 2011.
32. Su T, Liu H and Lu S: Cloning and identification of cDNA fragments related to human esophageal cancer. China J Oncol 20: 254-257, 1998 (In Chinese).
33. Mirabeau O, Perlas E, Severini C, Audero E, Gascuel O, Possenti R, Birney E, Rosenthal N and Gross C: Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Res 17: 320-327, 2007.
34. Chen C, Yang HL, Chen KW, Wang GL, Lu J, Yuan Q, Gu YP and Luo ZP: High expression of survivin in sacral chordoma. Med Oncol 30: 529, 2013.